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Abstract Transfection has become an everyday tech-
nique widely used for functional studies in living cells. The
choice of the particular transfection method is usually
determined by its efficiency and toxicity, and possible
functional consequences specific to the method used are
normally overlooked. We describe here that nucleofection,
a method increasingly used because of its convenience and
high efficiency, increases the metabolic rate of some cancer
cells, which can be misleading when used as a measure of
proliferation. Moreover, nucleofection can alter the sub-
cellular expression pattern of the transfected protein. These
undesired effects are independent of the transfected nucleic
acid, but depend on the particular cell line used. Therefore,
the interpretation of functional data using this technology
requires further controls and caution.
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Introduction
Transfection is the process of introducing foreign nucleic
acids into a cell. There are many different methods to
transfect cells, such as cationic polymers [1], precipitation
with calcium phosphate [2], lipid-based transfection [3, 4],
microinjection/gene gun [5] and electroporation [6].
Among them, electroporation-based technologies have
gained popularity because of their efficiency and relatively
low toxicity. Nucleofection is a form of electroporation
that combines electrical pulses with specific solutions
(adapted to the target cell line) to induce direct probe
transfer into the cell nucleus [7]. Nucleofection results in
higher transfection efficiency and less inter-experimental
variation than lipid-based transfection and is widely used
for primary cells and cell lines. In fact, it is frequently the
first choice for the transfection of primary cells, and often
the only non-viral method with reasonable yield. More-
over, electroporation-based transfection has not been
described to cause off-target effects by itself.
Transfection of a foreign DNA or RNA into a cell is an
important tool for cellular biology and a frequent experi-
mental outlook after the transfection is the subsequent
measurement of proliferation, often through redox-based
technologies, like MTT [8], AlamarBlue [9] or related
methods. These methods are based on the reduction of a
reagent in living mitochondria to render a colored or
fluorescent product. A linear correlation between redox-
based and other methods to determine cell proliferation
(cell counting, bromodeoxy-uridine or [3H]-thymidine
incorporation, flow cytometry) has been repeatedly repor-
ted [10–12], and the simplicity of redox-based approaches
makes them the preferred method in many laboratories.
With the aim of extending our panel of studied lines, we
decided to migrate our transfection methodology to
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nucleofection because of difficulties in transfecting some
cell lines. In the process, we compared the results of pro-
liferation experiments from cell lines transfected by our
already standardized lipofection [13] or nucleofection.
Here we report alterations of the MTT signal that is directly
dependent on nucleofection of several, but not all, cell lines
tested. The transfection method also altered the subcellular
distribution of the recombinant protein in some cell lines.
Materials and methods
Cell lines
All cell lines were obtained from DSMZ (Braunschweig,
Germany). The lines used in this study were the prostate-
derived adherent cell lines LNCaP (ACC 256), PC3 (ACC
465) and DU145 (ACC 261); the rhabdomyosarcoma-
derived cell line TE671 (ACC 263), the mouse fibroblast
NIH-3T3 (ACC 59) and the leukemia-derived suspension
cell lines K562 (ACC 10) and PLB895 (ACC 139). Each
cell line was propagated and maintained according to the
instructions of the provider.
Transfection
Cells were transfected using either Lipofectamine 2000
(Invitrogen GmbH, Karlsruhe, Germany), Dreamfect (OZ
Biosciences, Marseille, France), or Amaxa Nucleofection
(Lonza, Cologne, Germany). Cells were plated 1 day before
chemically based transfections, which were performed in
OptiMEM medium. The cells were incubated with the siRNA
or the vehicle for 6 h, or overnight for DNA. After the 6 h
incubation period, cells were seeded in 96-well plates and
allowed to recover for 24–96 h before proliferation assays
were performed. Cells treated only with OptiMEM and the
corresponding vehicle were included as controls. Amaxa
Nucleofection was performed according to the instructions of
the provider using the following solution/program for each
cell line: LNCaP, R/T-009; PC3, V/T-013; DU145, L/A-023;
TE671, L/R-005; K562, V/T-003; PLB895, V/C-023 and
NIH-3T3, R/A-024. Adherent cells were plated after nucleo-
fection and allowed to recover for 24–96 h prior to metabolic
activity determinations. Suspension cells were seeded for
proliferation assays after 24 h recovery.
Real time PCR
Total RNA was isolated from all cell lines using the
RNeasy mini isolation kit for animal cells (Qiagen, Hilden,
Germany). cDNA synthesis and real time PCR were per-
formed as previously described [13, 14]. Data analysis was
performed using the -2DDCT method.
Proliferation assay
Cell proliferation of the adherent cell lines was determined
by measuring the metabolic activity via reduction of the
tetrazolium salt MTT (3-[4,5-dimethylthiazol-2]-2,5-
diphenyltetrazolium bromide; Sigma, Munich, Germany)
for adherent cell lines or via the reduction of resazurin to
resorufin (AlamarBlue; Invitrogen) in the case of non-
adherent cell lines. Cells were plated at a density of
10000–20000 cells/ml. MTT (5 mg/ml) was added to the
cultures 24–96 h after transfection. Two hours later, the
reaction was stopped and the product solubilized using 10%
SDS in 0.01 M HCl. After overnight incubation, the color
was read at 562 nm. AlamarBlue was added to the culture of
non-adherent cell lines at 24 and 48 h after the transfection.
Following 2 h incubation, the color was read at 570 nm.
Growth rate and viability
VybrantTM DiO (Invitrogen) was added to the cultures after
transfection. Following incubation of 20 min, cells were
seeded into 6-well plates and harvested at different time
points (2, 4 and 6 days). The data was measured using the
BD FACSAria flow cytometer (Becton Dickinson, Hei-
delberg, Germany). The fluorophore was excited at 488 nm
and fluorescence collected using a LP502 dichroic mirror
and BP510/20 filter. The analysis of doubling-time was
performed using the mean fluorescence given by FACS-
Diva software (Becton Dickinson) as previously described
[15]. To measure cellular viability, cells were harvested 2,
4 and 6 days after transfection. Samples were washed with
PBS and propidium iodide (0.1 lg/ml) was added to the
mix. Cells were incubated for 2–5 min and analyzed using
the BD FACSAria flow cytometer. Propidium iodide
positive cells were considered dead cells.
Cell cycle
Following transfection, cells were seeded into 6-well plates
and harvested at different time points (24, 48 and 72 h). Cells
were washed with PBS and the pellet was resuspended in a
solution containing: propidium iodide (50 lg/ml), saponin
(0.3%) and RNase (100 U/ml) in PBS. After 15 min incu-
bation at 4C, samples were analyzed with BD FACSAria
flow cytometer. The propidium iodide was excited at 488 nm
and fluorescence collected using a LP595 dichroic mirror
and BP610/20 filter. The data were analyzed using FlowJo
software (Tree Star Inc., Ashland, OR, USA).
Fluorescence microscopy
Cells were transfected using either Amaxa nucleofection or
PolyFect. In the first case, the cells were transfected in
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suspension and then plated on glass coverslips; in the case
of Polyfect, cells were transfected directly on the glass
coverslips. 48 h after transfection, the cells were fixed in
10% buffered formalin, nuclei were stained with ToPro3
and coverslips mounted using ProLong Gold antifade
reagent. The preparations were imaged using a conven-
tional epifluorescence microscope (Axioskop II) or a con-
focal microscope (LSM 510Meta, Zeiss, Jena, Germany).
Statistical analysis
Unpaired t test and one-way ANOVA were performed for
comparison of the values. The software GraphPad Prism
version 4 was applied for the analysis.
Results
Transfection efficiency
We first compared the efficiency of knockdown using
chemical or electrical transfection. To do this, we com-
pared the knockdown efficiency of a GAPDH siRNA by
real time RT-PCR that has been repeatedly used in previ-
ous reports [13, 16]. Since the transfected sequence was the
same in all cases, we assumed that the knockdown level
would be proportional to the transfection efficiency for a
given cell line. We used a commercial negative control as
reference, and the transferrin receptor as PCR reference
gene.
Figure 1 shows the changes in GAPDH RNA content in
four different cell lines using lipo- or nucleofection. We
observed a larger effect using nucleofection for TE671
(P \ 0.0005) and using lipofection for DU145 and LNCaP
(P \ 0.05), which may reflect a better transfection
efficiency. The minimal reduction observed was in the
order of 50%. The knockdown of mRNA for GAPDH was
achieved in all cases regarding the transfection method
used.
Metabolic activity
We then performed AlamarBlue (non-adherent cell lines)
or MTT (adherent cell lines) tests to assess the proliferation
of cells upon knockdown of GAPDH. Since the enzyme is
required for glycolysis, we expected a reduction in meta-
bolic activity in both assays that should be related to
decreased proliferation. However, we observed a non-
specific increase in metabolic activity in some cell lines
even due to incubation with the vehicle alone. The effect
was due solely to the transfection process, since it was in
fact observed in the absence of any nucleic acid (Fig. 2).
Moreover, controls using only the transfection solution but
not performing the transfection process did not alter the
metabolic rate of the cells studied (data not shown). The
increase in MTT signal was especially noticeable in
DU145 cells (Fig. 2a), which showed twice as much signal
after mock nucleofection than the control. LNCaP cells
(Fig. 2b), in contrast, showed no alteration of the MTT
signal attributable to the transfection process. TE671 and
PC3 cells showed 60 and 30% increase respectively
(Fig. 2c, d). Also, lipofection did not alter the MTT signal
in any of the prostate-derived cells lines tested. While
lipofection of GAPDH siRNA resulted in a dramatically
decreased MTT signal in all cell lines, the apparent effect
of nucleofection was strongly attenuated and only visible if
compared to control transfections. Although there was
some reduction of the MTT signal in most cell lines after
transfection with GAPDH siRNA as compared to scram-
bled siRNA, the effect even completely vanished in
Fig. 1 mRNA levels of GAPDH of tumor cells treated with
lipofection or nucleofection. Tumor cells were transfected with
vehicle only, scrambled or siRNA against GAPDH using lipofection
(white bars) or nucleofection (black bars). After 24 h, the levels of
GAPDH mRNA were measured by real-time PCR. Nucleofection and
lipofection are similarly effective in knocking down GAPDH mRNA.
Data was normalized against mock-transfect cells and it represents
mean ± standard error (n = 3). *P \ 0.0005; #P \ 0.05
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LNCaP. Importantly, LNCaP was the cell line that showed
least increase in MTT signaling by mock nucleofection.
A relevant methodological difference between lipo- and
nucleofection is that the latter is done in suspension and
therefore cell trypsinization is required before nucleofec-
tion. To account for this difference, we performed equiv-
alent experiments to the ones shown in Fig. 2 in cell lines
normally grown in suspension (Fig. 3). Vehicle nucleo-
fection increased the metabolic rate of K562 cells (Fig. 3a)
measured by AlamarBlue; this effect was statistically sig-
nificant when compared to exposure to the transfection
solution alone (not shown). The treatment even induced
doubling of the signal for PLB985 cells (an effect also
observed after lipofection; Fig. 3b). Therefore, we con-
clude that the changes in MTT signal are not due to tryp-
sinization. Intriguingly, lipofection also altered the
AlamarBlue signal in the non-adherent cell lines. In
PLB985 cells, lipofection clearly increased the signal,
while it decreased it in K562 cells.
Changes in MTT signal do not reflect changes
in proliferation
Since the methods applied to estimate proliferation rely on
the reducing ability of cells, we performed experiments to
test if the correlation between this parameter and the pro-
liferation is disrupted by nucleofection. We directly mea-
sured growth rate, cell cycle distribution and cell viability
by flow cytometry. In order to evaluate growth of the
studied cells, we used the Vybrant DiO, which is a mem-
brane-bound dye. It remains bound to the cell and is not
transferred from cell to cell nor does it affect the cellular
growth rate. Once a cell divides, each daughter cell will
receive one-half of the total dye present in the parent cell.
The growth rate can therefore be determined by the
reduction in the total fluorescence per cell. When com-
paring the growth rate of cells after nucleofection with no
or with control siRNA, no differences were observed
(Fig. 3a) that can be attributed to the transfection process.
We also determined the cell viability 4 days after
transfection by propidium iodide exclusion. As expected,
nucleofection using the appropriate solution does not
impair cell survival. Cells did not lose viability with the
treatment, with the exception of a slight decrease in the
case of DU145 cells (Fig. 3b), confirming the low toxicity
of nucleofection.
Finally, we also determined cell cycle distribution also
after nucleofection (Fig. 3c), since real changes in prolifer-
ation rates are often correlated with enrichment in the frac-
tion of cells in some phase of the cycle, typically G1. We did
not observe any effect in any of the cell lines tested. Although
unaltered cell cycle distribution does not unequivocally
indicate unaltered proliferation, it excludes cell arrests in any
phase of the cycle during the transfection process.
Altogether, our results strongly suggest that the
observed alterations in MTT and/or AlamarBlue signals do
Fig. 2 Metabolic activity of tumor cells. The metabolic activity of
tumor cells was measured either by MTT in the case of DU145,
LNCaP, PC3 and TE671 or AlamarBlue in the case of K562 and
PLB895. The effect on the metabolic activity after non-treatment
(control) or treatment with lipofection (white bars) or nucleofection
(grey bars) is shown. The assay was performed 96 h after the
transfection procedure. Data represents mean ± standard error
(n = 3). **P \ 0.001, #P \ 0.05, *P \ 0.01
2190 Mol Biol Rep (2012) 39:2187–2194
123
not reflect actual changes in cell proliferation, but rather
are artifactually induced by the transfection method itself.
Subcellular distribution
Nucleofection also changed the subcellular distribution of a
fluorescent fusion protein between the ion channel KV10.1
and the modified yellow fluorescent protein monomeric
Venus (KV10.1–Venus expressed in pcDNA3) in compar-
ison to chemical transfection in NIH-3T3 cells.
Chemical transfection resulted in a diffuse punctate
pattern throughout the whole cell (Fig. 4). Such a distri-
bution has repeatedly been reported in native systems and
heterologous systems using anti-KV10.1 antibodies [14,
17–19]. It has also been observed in HEK293 and CHO
cells using the same construct [14, 20]. Nucleofection of
NIH-3T3 cells was much more efficient than lipofection,
as expected from the data provided by the manufacturer
(http://www.lonzabio.com/no_cache/meta/cell-database/
cell-details/cell/123/), but induced a dramatically different
intracellular distribution pattern of the protein, with most
of the signal concentrated inside the nucleus. This appar-
ently aberrant expression pattern did not correlate with
signal intensity. We did not observe any alteration of the
distribution pattern of mVenus alone (also in pcDNA3)
regardless of the transfection method used. It is important
to keep in mind that the effect was specific for this par-
ticular cell line and no noticeable differences were
observed regarding protein distribution in HEK293 cells
(data not shown).
Discussion
It is a general assumption that transfection can induce
changes in the behavior of cells. Recently, Mo et al showed
that the nucleofection process is able to disrupt the tight
junction fence and thereby alter the membrane polarity of
renal epithelial cells [21]. An important question that
remains open is if other cellular properties can be altered
by nucleofection. Electroporation-based technologies, par-
ticularly nucleofection, are popular transfection methods.
The reason for this growing popularity is that nucleofection
yields relatively high transfection efficiency also in diffi-
cult cell models, particularly primary cells. Our data is the
first indicative that nucleofection can induce dramatic
changes in the cellular behavior in downstream cell bio-
logical analysis.
The effects of electric fields (low-, intermediate- and
high-intensity) on cells are not entirely understood. Due to
biomedical engineering, a large body of literature on the
application of electrical pulses has been generated and is
still actively growing. Electroporation uses high electric
fields to permeabilize biomembranes in a reversible way by
creating structural distortions. The technique was first used
by Neumann et al. [22] to allow the uptake of DNA into
Fig. 3 Growth rate and viability and cell cycle measurement of
tumor cells after nucleofection treatment. a 6 days after transfection,
the growth rate of PC3 (white bars), LNCaP (grey bars) and DU145
(black bars) was measured by flow cytometry using Vibrant DiO.
b Viability was measured by propidium iodide-exclusion at 6 days
after transfection. c Cell cycle was determined by flow cytometry at
4 days after transfection. Nucleofection had no effect on the growth
rate, viability or cell cycle phases. Prostate-derived tumor cells were
transfected with vehicle only (grey bars) or scrambled siRNA (black
bars) using nucleofection. Non-transfected cells (white bars) were
used as control. Data represents mean ± standard error (n = 3)
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cells. Although the information about electrical pulse
intensity, frequency and duration used in each cell trans-
fection by nucleofection, as well as the exact transfection
solution composition is not publicly available, in general
high-intensity and low frequency pulses are used for
electroporation, since in this way heating of the sample is
minimized and but still are capable of creating nanometer-
size pores in the plasma membrane as well as the mem-
brane of intracellular organelles. The dimension and
distribution of the membrane electropores formed typically
depend on both the magnitude and pulse durations of the
applied electric fields [23]. Besides cellular electropora-
tion, the use of high-intensity electrical fields has been
reported to induce intracellular calcium release [24],
damage of nucleic acids [24], and destruction of cancer
cells [24–27]. Recently, it has been shown that electrical
stimuli at low-intensity (\5 lA) and low AC frequency
(50 Hz) are able to inhibit cell cycle progression by
affecting potassium channels when applied to dividing
cells [28, 29]. Moreover, low-intensity and intermediate
AC frequency (100–300 kHz) electrical fields prevent
tumor proliferation by interfering with cytoskeletal
mechanisms responsible for the formation of mitotic
spindles [29]. Our observations add the nucleofection
method to the conditions that render metabolic assays
unreliable to estimate proliferation [30], but importantly in
a cell line-specific fashion. Moreover, we detected dra-
matic differences on the distribution of the KV10.1–Venus
in NIH-3T3 cells, an effect that was neither observed for
the same protein in other cell lines, nor for Venus alone in
this cell line. This could reflect a permeabilization of the
nuclear envelope during an extended period, which would
affect the distribution of certain proteins. Imaging was
performed 48 h after transfection; it is not clear if the
nuclear electropores had been closed after that time,
because we do not know if the protein accumulated in the
nucleus was trapped there during the first hours of pro-
duction and could not escape when the cell completely
recovered.
Our data indicate that nucleofection can induce dramatic
changes in the cellular behavior in cell biological down-
stream analysis. The changes are not constant for all cell
lines, nor can they be easily predicted. It continues to be a
very efficient, and in many cases, the method of choice, but
Fig. 4 Intracellular distribution of Venus-labeled KV10.1 channels
varies with the method of transfection in NIH-3T3 cells. a Nucleo-
fection induced intense signals in and around the nucleus (stained
with ToPro3) in virtually all cells (lower panels) while lipofection
(upper panels) gave rise to a comparable phenotype only in rare cases,
and intense intranuclear signals were never observed. Scale bar:
10 lm. b Examples of 0.5 lm-thick confocal slices of cells
transfected with a KV10.1–Venus construct using nucleofection.
The protein is located in intranuclear aggregates
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caution is advisable when interpreting data obtained after
cell nucleofection. We propose that certain standards have
to be set for the publication of transfection experiments.
When applying any transfection method to a new cell line
proper control experiments have to be performed at the
beginning of any study. This should include the evaluation
if the chosen method for metabolic rate changes is truly
linear to cell proliferation and immunocytochemical sta-
inings to ensure that the transfected protein is properly
distributed in the cell. All following experiments have to
include controls like vehicle transfections to ensure correct
comparisons. Such standards will greatly increase the
reliability of reported data.
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